Christine Lang

Christine Lang (born December 23, 1957, in Bochum, West Germany) is a German microbiologist and entrepreneur.

Lang was raised in Bochum, West Germany, with her brother Joachim Lang.

She studied biology from 1976 to 1981 at the Ruhr-Universität Bochum and the University of Sussex.

In 1985, she obtained a Dr. rer.

nat.

in biology in Bochum on the molecular genetics of fungi, with her thesis entitled "Extrachromosomal in vitro genetics in fungi: chondriome vectors in yeasts."

She then worked in industrial research at the Hüls Chemie research center (now Marl Chemical Plant).

In 1993 she moved to the Technical University of Berlin and habilitated in the field of microbiology and molecular genetics under the supervision of Ulf Stahl.

At the TU Berlin she is an adjunct professor of microbiology and molecular genetics and teaches genetics in biotechnology.

In 2001 Lang and Ulf Stahl founded Organobalance GmbH, a company specializing in microbial strain development, which has been part of the Danish Novozymes A / S since September 2016.

In 2010, together with Bernd Wegener, she founded Organobalance Medical AG, now Belano Medical AG.

Since 2012, Christine Lang, together with the agricultural economist Joachim von Braun, chaired the Bioeconomy Council of the German Federal Government, which advises the German government on the further development of the bioeconomy in Germany.

Since March 2017 she is 1st Vice President of the Association for General and Applied Microbiology.

In addition to specialist publications, Christine Lang has also published books as an author and co-author.

As of July 1, 2018, Lang gave up her long-term position as managing director of Organobalance Novozymes Berlin.

Lang is involved in various associations: in the German Society of Chemical Engineering and Biotechnology e. V. and in the German Industry Association Biotechnology (a trade association in the Association of the Chemical Industry), where she is a member of the board.